No items found
We're sorry – there are no items in this archive.
Proper device programming and effective post-operative management are essential. Our videos cover the intricacies of device programming, troubleshooting, and long-term management strategies, helping you ensure the best possible outcomes for your patients.
We're sorry – there are no items in this archive.
Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.
Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?